A carregar...
Short‐acting erythropoiesis‐stimulating agents for anaemia in predialysis patients
BACKGROUND: The benefits of erythropoiesis‐stimulating agents (ESA) for chronic kidney disease (CKD) patients have been previously demonstrated. However, the efficacy and safety of short‐acting epoetins administered at larger doses and reduced frequency as well as of new epoetins and biosimilars rem...
Na minha lista:
| Publicado no: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Ltd
2017
|
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6464724/ https://ncbi.nlm.nih.gov/pubmed/28066881 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011690.pub2 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|